Warning For Facebook “Likes” Reflects FDA Social Media Approach
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is revealing its views on social media use through individual enforcement actions and provisions in disparate guidances, in the absence of issuing an overarching guidance. A recent warning letter sheds light on the agency’s view of “liking” something on Facebook.
You may also be interested in...
FDA Policy Power Challenged In House Questions On Untitled Letters
Oversight and Investigations Subcommittee Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours. The Energy and Commerce Committee examines whether FDA use of untitled letters is “fair, effective and efficient in gaining compliance,” he says.
FDA Policy Power Challenged In House Questions On Untitled Letters
Oversight and Investigations Subcommittee Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours. The Energy and Commerce Committee examines whether FDA use of untitled letters is “fair, effective and efficient in gaining compliance,” he says.
FDA Policy Power Challenged In House Questions On Untitled Letters
House lawmakers want to know if FDA is aware of consequences of publishing letters during stock trading hours.